tiprankstipranks
GlaxoSmithKline (GB:GSK)
LSE:GSK
Holding GB:GSK?
Track your performance easily

GlaxoSmithKline (GSK) Financial Statements

710 Followers

GlaxoSmithKline Financial Overview

GlaxoSmithKline's market cap is currently ―. The company's EPS TTM is p0.616; its P/E ratio is 21.14; and it has a dividend yield of 4.60%. GlaxoSmithKline is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is p0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue£ 7.38B£ 7.83B£ 6.93B£ 9.78B£ 9.53B
Gross Profit£ 5.14B£ 5.41B£ 4.75B£ 6.09B£ 5.85B
EBIT£ 1.84B£ 1.21B£ 1.10B£ 2.81B£ 890.00M
EBITDA£ 1.84B£ 2.17B£ 1.73B£ 3.51B£ 1.26B
Net Income Common Stockholders£ 1.46B£ 10.35B£ 838.00M£ 1.80B£ 749.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 7.68B£ 7.16B£ 6.53B£ 13.98B£ 4.13B
Total Assets£ 60.15B£ 60.31B£ 89.05B£ 89.69B£ 79.10B
Total Debt£ 20.99B£ 22.11B£ 22.11B£ 33.33B£ 24.17B
Net Debt£ 13.31B£ 14.95B£ 15.58B£ 19.35B£ 20.04B
Total Liabilities£ 50.05B£ 51.60B£ 66.41B£ 67.06B£ 57.76B
Stockholders Equity£ 10.60B£ 9.15B£ 16.37B£ 16.18B£ 15.05B
Cash Flow-
Free Cash Flow£ 1.15B£ 841.00M£ 1.21B£ 1.94B£ 3.13B
Operating Cash Flow£ 1.91B£ 1.32B£ 1.64B£ 2.54B£ 3.77B
Investing Cash Flow£ -540.00M£ -4.09B£ -545.00M£ -3.59B£ -361.00M
Financing Cash Flow£ -1.34B£ -1.33B£ -4.49B£ 7.97B£ -2.77B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History

GlaxoSmithKline Debt to Assets

GlaxoSmithKline Cash Flow

GlaxoSmithKline Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis